GN downgrade "unsurprising" says analyst
Sonova and Demant’s downgrades earlier this week had put a damper on expectations for GN Hearing, assesses a Sydbank analyst.
by marketwire, translated by daniel pedersen
Expectations for GN Hearing’s report, which was published ahead of schedule late Wednesay, were already subdued after the hearing aid market leader Sonova and Danish competitor Demant both downgraded financial expectations earlier this week.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
GN seeks OTC approval for flagship product
For subscribers
GN Hearing downgrades organic growth forecast
For subscribers
